Earnings Report: Here’s what to expect from Neogen (NASDAQ:NEOG)

0
184

Earnings results for Neogen (NASDAQ:NEOG)

Neogen Corporation is expected* to report earnings on 09/22/2020 before market open. The report will be for the fiscal Quarter ending Aug 2020. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.27. The reported EPS for the same quarter last year was $0.28.

Neogen last released its quarterly earnings data on July 21st, 2020. The reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.01. The business earned $109.10 million during the quarter, compared to the consensus estimate of $112.15 million. Its revenue for the quarter was down .8% compared to the same quarter last year. Neogen has generated $1.13 earnings per share over the last year and currently has a price-to-earnings ratio of 66.0. Neogen has confirmed that its next quarterly earnings report will be published on Tuesday, September 22nd, 2020.

Analyst Opinion on Neogen (NASDAQ:NEOG)

3 Wall Street analysts have issued ratings and price targets for Neogen in the last 12 months. Their average twelve-month price target is $81.50, predicting that the stock has a possible upside of 9.29%. The high price target for NEOG is $88.00 and the low price target for NEOG is $75.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of “Hold.”

Neogen has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings. According to analysts’ consensus price target of $81.50, Neogen has a forecasted upside of 9.3% from its current price of $74.57. Neogen has only been the subject of 3 research reports in the past 90 days.

Dividend Strength: Neogen (NASDAQ:NEOG)

Neogen does not currently pay a dividend. Neogen does not have a long track record of dividend growth.

Insiders buying/selling: Neogen (NASDAQ:NEOG)

In the past three months, Neogen insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $454,934.00 in company stock. Only 0.90% of the stock of Neogen is held by insiders. 92.55% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Neogen (NASDAQ:NEOG

Earnings for Neogen are expected to grow by 12.40% in the coming year, from $1.21 to $1.36 per share. The P/E ratio of Neogen is 65.99, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.37. The P/E ratio of Neogen is 65.99, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.63. Neogen has a PEG Ratio of 6.31. PEG Ratios above 1 indicate that a company could be overvalued. Neogen has a P/B Ratio of 5.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here